IHC - Napsin A |Test |Sprint Diagnostics

No, fasting is not required for this test. The test is conducted on tissue samples, typically acquired through a biopsy or surgical procedure.

No specific preparation is necessary for the patient as the tissue sample is generally obtained by a healthcare professional during a biopsy or surgery.

This test is generally recommended when there's a suspicion of lung cancer, often following imaging tests or if symptoms are suggestive of lung cancer.

The test measures the presence or absence of Napsin A, a protein typically found in specific types of lung tumors. It helps in distinguishing between different types of lung cancers.

The frequency of this test depends on your doctor's recommendation, typically it is done during the diagnostic process or when monitoring the effectiveness of treatment.

The interpretation of the Napsin A IHC test relies on whether Napsin A is detected or not, rather than a numerical value. A positive result indicates the presence of Napsin A, suggestive of certain types of lung cancer.

As this test is performed on tissue samples, the main precautions relate to the biopsy or surgical procedure used to obtain the sample.

Napsin A levels are influenced by nonmodifiable factors like the presence of certain types of lung or renal cancers. There are no known modifiable factors affecting Napsin A expression.

You should consult an oncologist if your Napsin A IHC test results are abnormal. They will guide you through the implications of the results and discuss the next steps.

While Napsin A is primarily associated with lung cancer, it may also be expressed in some renal cancers. Therefore, the test result must be interpreted alongside other clinical and diagnostic information.

While Napsin A is predominantly found in lung tissue, it can also be present in kidney tissues. However, its detection is most commonly associated with certain types of lung cancer.

There are no specific medication restrictions before the test. However, you should always inform your doctor about any medications you're taking prior to any surgical or biopsy procedure.

No, this test requires a tissue sample usually obtained via a biopsy or surgical procedure. Therefore, it needs to be done in a medical facility by a healthcare professional.

While the Napsin A IHC test is highly specific, it must be interpreted in conjunction with other tests and clinical information for a comprehensive diagnosis.

In the fight against cancer, early and accurate diagnosis plays a pivotal role. The Napsin A IHC test is one of the vital tools that contribute to precise disease detection and subclassification, ultimately influencing the best treatment course. Always remember, the journey of diagnosis and treatment is one that you don't walk alone. Your healthcare team will be there every step of the way, guiding and supporting you through each decision.